{"id":"W2905845365","doi":"10.1016/j.eururo.2018.12.015","title":"Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; Abbotsford Veterinary Clinic; Fraser Health; BC Cancer Agency","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Prednisone; Abiraterone; Randomized controlled trial; Quality of life (healthcare); Oncology; Internal medicine; Abiraterone acetate; Androgen deprivation therapy; Urology; Cancer; Androgen receptor; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001951731,0.0002228998,0.00123311,0.0001549992,0.0001240195,0.00001101702,0.0001067643,0.00004482401,0.00006143992],"category_scores_gemma":[0.001124494,0.0001537688,0.00009790566,0.0002208705,0.0004917295,0.00006775144,0.00004907486,0.0001828859,0.000008537301],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001787672,"about_ca_system_score_gemma":0.0008143166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002544562,"about_ca_topic_score_gemma":0.000933298,"domain_scores_codex":[0.9956998,0.001641896,0.001409595,0.0004954408,0.0003122732,0.0004409761],"domain_scores_gemma":[0.9976885,0.0007510814,0.0007060134,0.000339926,0.0003119498,0.0002025553],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9919632,0.001210399,0.000187328,0.00006522996,0.0006528515,0.00001885157,0.003464185,0.00003399827,0.0004368088,0.00002956305,0.0002324014,0.001705166],"study_design_scores_gemma":[0.9558589,0.03808064,0.00494234,0.00005789827,0.0002005494,2.967517e-7,0.00005802194,0.0002353982,0.0001706296,0.00004022153,0.0002323402,0.0001227679],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892812,0.0006777603,0.00005389745,0.002255296,0.0003680877,0.005483684,0.001575006,0.0000355288,0.0002695905],"genre_scores_gemma":[0.9973588,0.00007453486,0.0004429901,0.0001704526,0.0001204163,0.0001980266,0.001288768,0.00004338498,0.0003026305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03687024,"threshold_uncertainty_score":0.6270511,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07043159014875042,"score_gpt":0.3704435745394552,"score_spread":0.3000119843907048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}